Empower the Immune System to Treat Glioblastoma: DNA as Medicine
Time: 3:05 pm
day: Day One
Details:
- Explore DNA medicines that have the potential to create robust,
antigen-specific T cell responses - Evaluate Inovio’s DNA medicine, INO-5401 has promising, early data in
GBM showing early efficacy, and immunogenicity - Discuss Inovio’s DNA medicine, its technology, and other promising
approaches to GBM therapy will be discussed